Of those 934 million, only 2,2% (!) are currently treated with a Branded Anti-Obesity Medication (BAOM)
This treatment is tailored to help patients reduce food intake, control cravings, and achieve meaningful weight loss results
Those in the very highest percentile of Lp(a) levels had a raised risk of ischemic stroke and cardiovascular death, the researchers reported in JAMA Cardiology
Clinical assessments were conducted every 3 months to evaluate efficacy, measured as percentage of total weight loss (%TWL), excess weight loss (%EWL), changes in BMI, and improvement in comorbidities, as well as tolerance, monitored for adverse effects including gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) and discontinuation rates
The American Association of Clinical Endocrinologists and the American Diabetes Association both emphasize site rotation as a key component of injectable medication management